Alnylam (ALNY) Announces Restructuring: Will Cut 33% of Workforce, Sees $4M in Charges
Tweet
Share
E-mailGet Alerts ALNY Hot Sheet
Join SI Premium – FREE
Alnylam (Nasdaq: ALNY) announces restructuring, aligning resources to focus on Alnylam 5x5(TM) product strategy. To cut 33 percent of its headcount, sees $4 million in restructuring costs.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stifel Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
- TD Cowen Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
- Truist Securities Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Create E-mail Alert Related Categories
Corporate News, Trading HaltsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
